Your browser doesn't support javascript.
loading
Treatable traits in the NOVELTY study.
Agustí, Alvar; Rapsomaniki, Eleni; Beasley, Richard; Hughes, Rod; Müllerová, Hana; Papi, Alberto; Pavord, Ian D; van den Berge, Maarten; Faner, Rosa.
  • Agustí A; Càtedra Salut Respiratoria, Universitat Barcelona, Barcelona, Spain.
  • Rapsomaniki E; Servei Pneumologia, Respiratory Institute, Hospital Clinic, Barcelona, Spain.
  • Beasley R; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Hughes R; CIBER Enfermedades Respiratorias, Barcelona, Spain.
  • Müllerová H; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Papi A; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Pavord ID; External Scientific Engagement, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • van den Berge M; Respiratory & Immunology, Medical and Payer Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Faner R; Department of Respiratory Medicine, Medical School, University of Ferrara, Ferrara, Italy.
Respirology ; 27(11): 929-940, 2022 11.
Article en En | MEDLINE | ID: mdl-35861464
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article